Showing results (81-90 of 466) with videos related to
Sort By:
Pageof 47
The American Journal of Gastroenterology|April 22, 2026
Sex does not impact the performance of non-invasive tests for clinically significant portal hypertension in cACLDPaula Höfinger, Helena Schluchter, Georg Semmler, et al.JHEP Reports : Innovation in Hepatology|July 17, 2025
Risk of portal hypertensive complications preventable by TIPS in patients with ascitesLorenz Balcar, Marta Tonon, Joan Valls, et al.Journal of Hepatology|January 23, 2022
Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLDBernhard Scheiner, Lorenz Balcar, Rosa Johanna Nussbaumer, et al.Alimentary Pharmacology & Therapeutics|November 6, 2025
Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease-Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute-on-Chronic Liver Failure and DeathMathias Jachs, Tânia Carvalho, Benedikt Simbrunner, et al.Journal of Hepatology|July 6, 2021
Polyploidy control in hepatic health and diseaseValentina C Sladky, Felix Eichin, Thomas Reiberger, et al.Journal of Hepatology|March 1, 2024
Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver diseaseKatrine Holtz Thorhauge, Georg Semmler, Stine Johansen, et al.Journal of Hepatology|May 7, 2022
Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) and spleen diameter predict outcomes in ACLDNina Bastati, Lucian Beer, Ahmed Ba-Ssalamah, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 6, 2020
Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal HypertensionKatharina Wöran, Georg Semmler, Mathias Jachs, et al.JHEP Reports : Innovation in Hepatology|December 3, 2024
Metabolomic profiles differentiate between porto-sinusoidal vascular disorder, cirrhosis, and healthy individualsGeorg Semmler, Oleksandr Petrenko, Juanjo Jose Lozano, et al.Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2023
Carvedilol as the new non-selective beta-blocker of choice in patients with cirrhosis and portal hypertensionLaura Turco, Thomas Reiberger, Giovanni Vitale, et al.Pageof 47